These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


758 related items for PubMed ID: 17659875

  • 1. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM, Panegyres PK.
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [Abstract] [Full Text] [Related]

  • 2. [Cognitive impairment].
    Reuter F, Audoin B, Rico A, Malikova I, Ranjeva JP, Pelletier J.
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S113-22. PubMed ID: 19361675
    [Abstract] [Full Text] [Related]

  • 3. Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test.
    Claesson IM, Ytterberg C, Johansson S, Almkvist O, von Koch L.
    Mult Scler; 2007 Mar; 13(2):272-4. PubMed ID: 17439898
    [Abstract] [Full Text] [Related]

  • 4. The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
    Glanz BI, Healy BC, Rintell DJ, Jaffin SK, Bakshi R, Weiner HL.
    J Neurol Sci; 2010 Mar 15; 290(1-2):75-9. PubMed ID: 19944429
    [Abstract] [Full Text] [Related]

  • 5. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J, Arévalo MJ, Renom M, Alonso J, González I, Galán I, Montalban X, Rovira A.
    J Neurol Sci; 2009 Jul 15; 282(1-2):120-4. PubMed ID: 19157420
    [Abstract] [Full Text] [Related]

  • 6. The cognitive burden of multiple sclerosis in children.
    Banwell BL, Anderson PE.
    Neurology; 2005 Mar 08; 64(5):891-4. PubMed ID: 15753431
    [Abstract] [Full Text] [Related]

  • 7. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, Amato MP, De Stefano N.
    Neurology; 2009 Aug 18; 73(7):498-503. PubMed ID: 19641173
    [Abstract] [Full Text] [Related]

  • 8. Cognitive functioning in children and adolescents with multiple sclerosis.
    MacAllister WS, Belman AL, Milazzo M, Weisbrot DM, Christodoulou C, Scherl WF, Preston TE, Cianciulli C, Krupp LB.
    Neurology; 2005 Apr 26; 64(8):1422-5. PubMed ID: 15851734
    [Abstract] [Full Text] [Related]

  • 9. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G, Fredrikson S, Almkvist O.
    Eur Neurol; 2007 Apr 26; 57(4):193-202. PubMed ID: 17272938
    [Abstract] [Full Text] [Related]

  • 10. The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study.
    Scherer P, Penner IK, Rohr A, Boldt H, Ringel I, Wilke-Burger H, Burger-Deinerth E, Isakowitsch K, Zimmermann M, Zahrnt S, Hauser R, Hilbert K, Tiel-Wilck K, Anvari K, Behringer A, Peglau I, Friedrich H, Plenio A, Benesch G, Ehret R, Nippert I, Finke G, Schulz I, Bergtholdt B, Breitkopf S, Kaskel P, Reischies F, Kugler J.
    Mult Scler; 2007 Apr 26; 13(3):402-11. PubMed ID: 17439910
    [Abstract] [Full Text] [Related]

  • 11. Cognitive impairment in multiple sclerosis.
    Jongen PJ, Ter Horst AT, Brands AM.
    Minerva Med; 2012 Apr 26; 103(2):73-96. PubMed ID: 22513513
    [Abstract] [Full Text] [Related]

  • 12. Cognitive impairment and decline in different MS subtypes.
    Huijbregts SC, Kalkers NF, de Sonneville LM, de Groot V, Polman CH.
    J Neurol Sci; 2006 Jun 15; 245(1-2):187-94. PubMed ID: 16643951
    [Abstract] [Full Text] [Related]

  • 13. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.
    Benedict RH, Duquin JA, Jurgensen S, Rudick RA, Feitcher J, Munschauer FE, Panzara MA, Weinstock-Guttman B.
    Mult Scler; 2008 Aug 15; 14(7):940-6. PubMed ID: 18573822
    [Abstract] [Full Text] [Related]

  • 14. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP, Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, De Stefano N.
    Neurology; 2008 Aug 26; 71(9):632-8. PubMed ID: 18725589
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Assessment and rehabilitation of cognitive impairment in multiple sclerosis.
    Messinis L, Kosmidis MH, Lyros E, Papathanasopoulos P.
    Int Rev Psychiatry; 2010 Aug 26; 22(1):22-34. PubMed ID: 20233112
    [Abstract] [Full Text] [Related]

  • 19. [Cognitive dysfunction as a hidden multiple sclerosis related symptom relevant for an expert appraisal].
    Kraus J, Lohmann H, Evers S.
    Fortschr Neurol Psychiatr; 2009 Jan 26; 77(1):38-43. PubMed ID: 19101878
    [Abstract] [Full Text] [Related]

  • 20. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis.
    Benedict RH, Carone DA, Bakshi R.
    J Neuroimaging; 2004 Jul 26; 14(3 Suppl):36S-45S. PubMed ID: 15228758
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 38.